24-hour Lung Function in Subjects with Moderate to Very Severe COPD after Treatment with PT003 and Placebo MDI

Trial Identifier: PT003012
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT02347085
Start Date: February 2015
Primary Completion Date: June 2015
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.